A Study of Imlunestrant (LY3484356) in Healthy Women

NCT05509816 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Midazolam
DRUG: Imlunestrant

Sponsor

Eli Lilly and Company